Liu C, Liu Z, Jin K, Zeng H, et al. Integrative tumour mutation burden with CD39 and PD-L1 for the prediction of response to PD-L1 blockade and adjuvant chemotherapy in muscle-invasive bladder cancer patients. Br J Cancer 2022 Aug 23. pii: 10.1038/s41416-022-01943.
PMID: 35999267